Piramal Consumer Healthcare unveils Lacto Calamine identity after six decades
Brand marks six decades of skincare use and portfolio expansion
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Piramal Pharma
From Compliance to Commitment: How Piramal Pharma is Reimagining Sustainability in Pharma
In its fourth annual Sustainability Report, Piramal Pharma charts an evolution from foundational ESG reporting to embedding…
Supply chain leadership: Stepping into the spotlight
As pharma supply chains rise in strategic importance, its leaders must sharpen their business acumen and competencies to keep pace…
Pharma’s strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it’s a space where the allure of a $11.55…
Piramal Critical Care launches Chlorpromazine Hydrochloride for Injection, USP in the US
This launch is the latest in a series of recent product launches from the company in the generic injectables market
Piramal Pharma Solutions reaches settlement in legal dispute with VetDC
Piramal Pharma Solutions and VetDC settle for USD 407,400, resolving litigation without affecting company’s financial position
Piramal Pharma’s GHG commitment validated and approved by SBTi
Piramal has committed to reducing absolute scope 1 and 2 GHG emissions by 42 per cent by FY2030 from an FY2022 base year. It has…
Pharma sector gears up for Budget 2024-25; Calls for innovation and regulatory reforms
Just a day before the union budget 2024-25 announcement, experts in pharma sector are united in their call for regulatory reforms,…
Piramal Pharma announces consolidated results for Q2 and H1 FY2023
Revenue from operation grew by 11 per cent to Rs 3,202 crore versus Rs 2,889 crore in H1FY22
Piramal Pharma lists on BSE and NSE
Piramal Pharma includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organisation (CDMO);…